North America Extracellular Matrix Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Extracellular Matrix Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Extracellular Matrix Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Extracellular Matrix Market Regional Analysis

6.2 North America Extracellular Matrix Market Revenue 2019-2028 (US$ Thousand)

6.3 North America Extracellular Matrix Market Forecast Analysis

7. North America Extracellular Matrix Market Analysis – by Raw Material

7.1 Bovine

7.1.1 Overview
7.1.2 Bovine: North America Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

7.2 Porcine

7.2.1 Overview
7.2.2 Porcine: North America Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

7.3 Other Raw Material

7.3.1 Overview
7.3.2 Other Raw Material: North America Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

8. North America Extracellular Matrix Market Analysis – by Application

8.1 Soft Tissue Repair

8.1.1 Overview
8.1.2 Soft Tissue Repair: North America Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

8.2 Dural Repair

8.2.1 Overview
8.2.2 Dural Repair: North America Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

8.3 Wound Healing

8.3.1 Overview
8.3.2 Wound Healing: North America Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

8.4 Cardiac Repair

8.4.1 Overview
8.4.2 Cardiac Repair: North America Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

8.5 Pericardial Repair

8.5.1 Overview
8.5.2 Pericardial Repair: North America Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

8.6 Vascular Repair and Reconstruction

8.6.1 Overview
8.6.2 Vascular Repair and Reconstruction : North America Extracellular Matrix Market – Revenue and Forecast, 2019-2028 (US$ Thousand)

9. North America Extracellular Matrix Market – North America Analysis

9.1 Overview

9.2 North America

9.2.1 North America Extracellular Matrix Market Breakdown, by Key Country, 2022 and 2028 (%)
9.2.1.1 North America Extracellular Matrix Market – Revenue and Forecast Analysis – by Country
9.2.1.1 US: North America Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)

9.2.1.1.1 US: North America Extracellular Matrix Market Breakdown, by Raw Material
9.2.1.1.2 US: North America Extracellular Matrix Market Breakdown, by Application

9.2.1.2 Canada: North America Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)

9.2.1.2.1 Canada: North America Extracellular Matrix Market Breakdown, by Raw Material
9.2.1.2.2 Canada: North America Extracellular Matrix Market Breakdown, by Application

9.2.1.3 Mexico : North America Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)

9.2.1.3.1 Mexico : North America Extracellular Matrix Market Breakdown, by Raw Material
9.2.1.3.2 Mexico : North America Extracellular Matrix Market Breakdown, by Application

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Medtronic

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Merck Kgaa

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Mtf Biologics

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Smith & Nephew

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Anteris

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Aziyo

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Coloplast Group

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Baxter

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 DSM

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

12.10 Cook Biotech

12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

North America Extracellular Matrix Market

Analysis By Raw Material (Bovine, Porcine, and Other Raw Material), Application (Soft Tissue Repair, Dural Repair, Wound Healing, Cardiac Repair, Pericardial Repair, and Vascular Repair and Reconstruction)